Annual FCF
-$50.22 M
+$9.67 M+16.14%
31 December 2023
Summary:
Verona Pharma annual free cash flow is currently -$50.22 million, with the most recent change of +$9.67 million (+16.14%) on 31 December 2023. During the last 3 years, it has fallen by -$5.06 million (-11.21%). VRNA annual FCF is now -1477217.65% below its all-time high of $3400.00, reached on 31 December 2005.VRNA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$62.66 M
-$45.52 M-265.74%
30 September 2024
Summary:
Verona Pharma quarterly free cash flow is currently -$62.66 million, with the most recent change of -$45.52 million (-265.74%) on 30 September 2024. Over the past year, it has dropped by -$49.93 million (-392.30%). VRNA quarterly FCF is now -374.63% below its all-time high of $22.81 million, reached on 30 September 2021.VRNA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$103.81 M
-$49.93 M-92.65%
30 September 2024
Summary:
Verona Pharma TTM free cash flow is currently -$103.81 million, with the most recent change of -$49.93 million (-92.65%) on 30 September 2024. Over the past year, it has dropped by -$56.26 million (-118.29%). VRNA TTM FCF is now -2209.96% below its all-time high of -$4.49 million, reached on 31 March 2017.VRNA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.1% | -392.3% | -118.3% |
| 3 y3 years | -11.2% | -374.6% | -198.8% |
| 5 y5 years | -115.3% | -635.3% | -176.3% |
VRNA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.0% | +16.1% | -374.6% | at low | -263.4% | at low |
| 5 y | 5 years | -115.3% | +16.1% | -374.6% | at low | -263.4% | at low |
| alltime | all time | <-9999.0% | +16.1% | -374.6% | at low | -2210.0% | at low |
Verona Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$62.66 M(+265.7%) | -$103.81 M(+92.7%) |
| June 2024 | - | -$17.13 M(+25.7%) | -$53.89 M(-7.2%) |
| Mar 2024 | - | -$13.63 M(+31.0%) | -$58.07 M(+15.6%) |
| Dec 2023 | -$50.22 M(-16.1%) | -$10.40 M(-18.3%) | -$50.22 M(+5.6%) |
| Sept 2023 | - | -$12.73 M(-40.3%) | -$47.56 M(-10.1%) |
| June 2023 | - | -$21.31 M(+268.6%) | -$52.93 M(+3.4%) |
| Mar 2023 | - | -$5.78 M(-25.3%) | -$51.16 M(-14.6%) |
| Dec 2022 | -$59.89 M(+80.0%) | -$7.74 M(-57.2%) | -$59.89 M(-13.8%) |
| Sept 2022 | - | -$18.09 M(-7.4%) | -$69.48 M(+143.2%) |
| June 2022 | - | -$19.55 M(+34.7%) | -$28.57 M(-2.3%) |
| Mar 2022 | - | -$14.51 M(-16.2%) | -$29.23 M(-12.1%) |
| Dec 2021 | -$33.27 M(-26.3%) | -$17.32 M(-175.9%) | -$33.27 M(-4.3%) |
| Sept 2021 | - | $22.81 M(-212.9%) | -$34.75 M(-48.6%) |
| June 2021 | - | -$20.20 M(+8.9%) | -$67.62 M(+34.0%) |
| Mar 2021 | - | -$18.55 M(-1.3%) | -$50.48 M(+11.8%) |
| Dec 2020 | -$45.16 M(+5.2%) | -$18.80 M(+86.8%) | -$45.16 M(+19.8%) |
| Sept 2020 | - | -$10.06 M(+228.8%) | -$37.70 M(+4.3%) |
| June 2020 | - | -$3.06 M(-76.9%) | -$36.16 M(-16.3%) |
| Mar 2020 | - | -$13.23 M(+16.6%) | -$43.20 M(+0.7%) |
| Dec 2019 | -$42.92 M | -$11.35 M(+33.2%) | -$42.92 M(+14.2%) |
| Sept 2019 | - | -$8.52 M(-15.7%) | -$37.58 M(+25.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$10.11 M(-21.9%) | -$30.01 M(+9.8%) |
| Mar 2019 | - | -$12.95 M(+115.7%) | -$27.33 M(+17.2%) |
| Dec 2018 | -$23.32 M(-17.5%) | -$6.00 M(+532.2%) | -$23.32 M(-3.6%) |
| Sept 2018 | - | -$949.50 K(-87.2%) | -$24.19 M(-28.6%) |
| June 2018 | - | -$7.43 M(-16.9%) | -$33.86 M(+3.5%) |
| Mar 2018 | - | -$8.94 M(+30.0%) | -$32.71 M(+15.7%) |
| Dec 2017 | -$28.26 M(+300.9%) | -$6.87 M(-35.3%) | -$28.26 M(+32.1%) |
| Sept 2017 | - | -$10.62 M(+69.4%) | -$21.39 M(+98.7%) |
| June 2017 | - | -$6.27 M(+39.6%) | -$10.77 M(+139.6%) |
| Mar 2017 | - | -$4.49 M | -$4.49 M |
| Dec 2016 | -$7.05 M(-26.8%) | - | - |
| Dec 2015 | -$9.63 M(+64.5%) | - | - |
| Dec 2014 | -$5.85 M(+64.2%) | - | - |
| Dec 2013 | -$3.57 M(-15.1%) | - | - |
| Dec 2012 | -$4.20 M(+69.0%) | - | - |
| Dec 2011 | -$2.49 M(-5.7%) | - | - |
| Dec 2010 | -$2.64 M(-0.9%) | - | - |
| Dec 2009 | -$2.66 M(+32.5%) | - | - |
| Dec 2008 | -$2.01 M(-17.1%) | - | - |
| Dec 2007 | -$2.42 M(+237.9%) | - | - |
| Dec 2006 | -$717.10 K(<-9900.0%) | - | - |
| Dec 2005 | $3400.00 | - | - |
FAQ
- What is Verona Pharma annual free cash flow?
- What is the all time high annual FCF for Verona Pharma?
- What is Verona Pharma annual FCF year-on-year change?
- What is Verona Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Verona Pharma?
- What is Verona Pharma quarterly FCF year-on-year change?
- What is Verona Pharma TTM free cash flow?
- What is the all time high TTM FCF for Verona Pharma?
- What is Verona Pharma TTM FCF year-on-year change?
What is Verona Pharma annual free cash flow?
The current annual FCF of VRNA is -$50.22 M
What is the all time high annual FCF for Verona Pharma?
Verona Pharma all-time high annual free cash flow is $3400.00
What is Verona Pharma annual FCF year-on-year change?
Over the past year, VRNA annual free cash flow has changed by +$9.67 M (+16.14%)
What is Verona Pharma quarterly free cash flow?
The current quarterly FCF of VRNA is -$62.66 M
What is the all time high quarterly FCF for Verona Pharma?
Verona Pharma all-time high quarterly free cash flow is $22.81 M
What is Verona Pharma quarterly FCF year-on-year change?
Over the past year, VRNA quarterly free cash flow has changed by -$49.93 M (-392.30%)
What is Verona Pharma TTM free cash flow?
The current TTM FCF of VRNA is -$103.81 M
What is the all time high TTM FCF for Verona Pharma?
Verona Pharma all-time high TTM free cash flow is -$4.49 M
What is Verona Pharma TTM FCF year-on-year change?
Over the past year, VRNA TTM free cash flow has changed by -$56.26 M (-118.29%)